J9349 Injection, tafasitamab-cxix, 2 mg

Short descriptor: Inj., tafasitamab-cxix

✓ Active HCPCS Level II 2026
Open J9349 in the app →

Look up J9349 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J9349 is the HCPCS Level II code for Injection, tafasitamab-cxix, 2 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2021-04-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
tafasitamab-cxix
Dose / Unit
2 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J9349 with the canonical source and edition:

J9349 — Injection, tafasitamab-cxix, 2 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J9349

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J9349

Related Codes in Section J

← J9348 Inj. naxitamab-gqgk, 1 mg J9350 → Inj mosunetuzumab-axgb, 1 mg
J9342 Inj thiotepa nos 1 mg J9345 Inj, retifanlimab-dlwr, 1 mg J9347 Inj, tremelimumab-actl, 1 mg J9348 Inj. naxitamab-gqgk, 1 mg J9350 Inj mosunetuzumab-axgb, 1 mg J9351 Topotecan injection J9352 Injection trabectedin 0.1mg J9353 Inj. margetuximab-cmkb, 5 mg J9354 Inj, ado-trastuzumab emt 1mg J9355 Inj trastuzumab excl biosimi
Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial